Clinical Trial Update: Endocrine Therapy With Abemaciclib or Chemotherapy as Initial Metastatic Treatment in ER+/HER2- Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing endocrine therapy with abemaciclib to chemotherapy as initial treatment for ER-positive, HER2-negative metastatic breast cancer; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Estrogen Receptor-positive Metastatic Breast Cancer

Drugs mentioned

• Abemaciclib (abemaciclib)
• Chemotherapy (unspecified regimen)

Snippet

Sponsor: UNICANCER | Conditions: Cancer Metastatic | Phase 3 | Status: ACTIVE_NOT_RECRUITING